• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis.

作者信息

Huber K, Kirchheimer J C, Korninger C, Binder B R

机构信息

Department of Medical Physiology, University of Vienna, Austria.

出版信息

Thromb Res. 1991 Jun 1;62(5):491-500. doi: 10.1016/0049-3848(91)90022-o.

DOI:10.1016/0049-3848(91)90022-o
PMID:1910213
Abstract

We determined plasma levels of tissue-type plasminogen activator (t-PA) antigen, urokinase-type plasminogen activator (u-PA) antigen, and activity of the fast acting inhibitor of plasminogen activator (PAI-1) in patients with different stages of liver cirrhosis (Child A, B, and C) and in age and sex-matched healthy controls to investigate the contribution of the liver to the metabolism of these main components of the fibrinolytic system. For control purposes routine clotting parameters were also determined. In patients with the most severe form of liver cirrhosis (Child C) t-PA antigen levels were significantly elevated as compared to patients with Child A or Child B (p less than 0.05) or to controls (p less than 0.01). Furthermore, Child C patients exhibited significantly decreased PAI-1 plasma levels (p less than 0.05) as compared to controls. We were not able to demonstrate, however, any significant correlation between liver function and u-PA plasma levels. Furthermore, t-PA antigen and albumin plasma levels were negatively correlated (r = 0.48; p = 0.0015) and t-PA antigen and bilirubin were positively correlated (r = 0.46; p = 0.0022) thus indicating that the liver is mainly involved in the clearance of t-PA antigen. PAI-1 activity, however, seems to depend partially on synthesis by the liver as demonstrated by a positive correlation between PAI-1 and albumin (r = 0.33; p = 0.037). These physiologic liver functions are both progressively attenuated in severe liver damage and an increase of t-PA plasma levels and a decrease of PAI-1 might contribute to the higher fibrinolytic tendency observed in those patients.

摘要

相似文献

1
Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis.
Thromb Res. 1991 Jun 1;62(5):491-500. doi: 10.1016/0049-3848(91)90022-o.
2
Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.肝脏疾病中的组织型纤溶酶原激活剂、纤溶酶原激活剂抑制剂及激活剂-抑制剂复合物
J Clin Pathol. 1994 Mar;47(3):214-7. doi: 10.1136/jcp.47.3.214.
3
Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.青少年血液纤溶成分的年龄依赖性以及低剂量口服避孕药对青少年凝血和纤溶的影响。
Thromb Haemost. 1988 Dec 22;60(3):361-4.
4
[Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].[冠状动脉疾病患者纤溶酶原激活物抑制剂活性增加导致纤溶能力下降]
Helv Chir Acta. 1992 Jan;58(4):503-8.
5
Fibrinolysis and coagulation in patients with infectious disease and sepsis.传染病和脓毒症患者的纤维蛋白溶解与凝血
Thromb Haemost. 1991 Mar 4;65(3):291-5.
6
Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.优球蛋白凝块溶解时间与组织型纤溶酶原激活物及纤溶酶原激活物抑制剂1血浆水平之间的关系。
Thromb Haemost. 1990 Feb 19;63(1):82-6.
7
The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis.静脉淤滞后纤溶酶原激活剂(组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂)及纤溶酶原激活剂抑制剂-1的释放
Blood Coagul Fibrinolysis. 1992 Feb;3(1):33-8. doi: 10.1097/00001721-199202000-00006.
8
Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.正常受试者的纤维蛋白溶解——纤溶酶原激活物抑制剂与纤维蛋白溶解系统其他成分的比较
Thromb Haemost. 1988 Apr 8;59(2):299-303.
9
[The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].慢性乙型肝炎后不同阶段肝硬化患者血浆中尿激酶型纤溶酶原激活物、尿激酶型纤溶酶原激活物受体及纤溶酶原激活物抑制剂-1的水平
Zhonghua Gan Zang Bing Za Zhi. 2004 Feb;12(2):82-4.
10
Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
Thromb Haemost. 1989 Sep 29;62(2):651-3.

引用本文的文献

1
Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most?肝硬化中的自发性出血或血栓形成:最应担心的是什么?
World J Hepatol. 2015 Jul 18;7(14):1818-27. doi: 10.4254/wjh.v7.i14.1818.
2
Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis?纤维蛋白溶解功能降低在肝硬化患者非肿瘤性门静脉血栓形成过程中起作用吗?
Intern Emerg Med. 2014 Jun;9(4):397-403. doi: 10.1007/s11739-013-0929-7. Epub 2013 Mar 17.
3
Viral cirrhosis: an overview of haemostatic alterations and clinical consequences.
病毒性肝硬化:止血改变及其临床后果概述。
Mediterr J Hematol Infect Dis. 2009 Dec 30;1(3):e2009033. doi: 10.4084/MJHID.2009.033.
4
Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.肝脏疾病中的组织型纤溶酶原激活剂、纤溶酶原激活剂抑制剂及激活剂-抑制剂复合物
J Clin Pathol. 1994 Mar;47(3):214-7. doi: 10.1136/jcp.47.3.214.
5
Elevated urokinase-type plasminogen activator plasma levels are associated with deterioration of liver function but not with hepatocellular carcinoma.
J Gastroenterol. 1994 Dec;29(6):745-50. doi: 10.1007/BF02349281.